Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matilde Buzzi

Showing results (21-30 of 23) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 23 results.
Clinical Ophthalmology (Auckland, N.Z.)|December 10, 2025
Comparison of Amniotic Membrane Extract and Insulin Eye Drops for the Management of Persistent Epithelial Defects: A Multicenter Retrospective StudyMatilde Buzzi, Alessandra Mancini, Livio Vitiello, et al.
American Journal of Ophthalmology|March 2, 2026
Correcting Astigmatism Using Toric Intraocular Lenses During Cataract SurgeryJan-Willem H Verstraaten, Matilde Buzzi, Mouayad Masalkhi, et al.
Ophthalmology and Therapy|May 15, 2026
A Multicenter, Real-World Experience with Polyhexamethylene Biguanide (PHMB) 0.08% Monotherapy for Treating Acanthamoeba Keratitis: A Retrospective Review of 39 CasesKarl Anders Knutsson, Antonio Di Zazzo, Emilio Pedrotti, et al.
Pageof 3

Showing results (21-30 of 23) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 23 results.
Clinical Ophthalmology (Auckland, N.Z.)|December 10, 2025
Comparison of Amniotic Membrane Extract and Insulin Eye Drops for the Management of Persistent Epithelial Defects: A Multicenter Retrospective StudyMatilde Buzzi, Alessandra Mancini, Livio Vitiello, et al.
American Journal of Ophthalmology|March 2, 2026
Correcting Astigmatism Using Toric Intraocular Lenses During Cataract SurgeryJan-Willem H Verstraaten, Matilde Buzzi, Mouayad Masalkhi, et al.
Ophthalmology and Therapy|May 15, 2026
A Multicenter, Real-World Experience with Polyhexamethylene Biguanide (PHMB) 0.08% Monotherapy for Treating Acanthamoeba Keratitis: A Retrospective Review of 39 CasesKarl Anders Knutsson, Antonio Di Zazzo, Emilio Pedrotti, et al.
Pageof 3